BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4032756)

  • 41. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):805-10. PubMed ID: 6882000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Phase I clinical study of TT-62. Research group of TT-62].
    Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
    [No Abstract]   [Full Text] [Related]  

  • 47. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Internal treatment of carcinoma with the cytostatic Proresid].
    Schärtl W
    Munch Med Wochenschr; 1966 Jan; 108(2):112-4. PubMed ID: 5341497
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
    Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Phase I study of a new floxuridine derivative, 2'-deoxy-3', 5'-di-O-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine (FF-705)].
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):143-9. PubMed ID: 6230054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H; Ogawa M; Miyamoto H; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Usui N; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):138-42. PubMed ID: 6696455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
    Kantarjian HM; Gandhi V; Kozuch P; Faderl S; Giles F; Cortes J; O'Brien S; Ibrahim N; Khuri F; Du M; Rios MB; Jeha S; McLaughlin P; Plunkett W; Keating M
    J Clin Oncol; 2003 Mar; 21(6):1167-73. PubMed ID: 12637486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Potentiation of antineoplastic agents--significance of combination with urokinase].
    Yamamoto M; Yamada T; Fukunaga K; Nagashima A; Nagamatsu S
    Gan No Rinsho; 1971 Oct; 17(10):750-9. PubMed ID: 5166830
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of human tumour cell responses to cisplatin and ZD0473 with and without irradiation.
    Raaphorst GP; Yang DP; Li LF; Malone S
    Anticancer Res; 2004; 24(2B):613-8. PubMed ID: 15161002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of 5'-deoxy-5-fluorouridine between older cancer patients versus younger cancer patients].
    Sumimura J; Morimoto Y; Miyazaki M; Ishikawa S; Nagai I
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):561-4. PubMed ID: 10097759
    [No Abstract]   [Full Text] [Related]  

  • 59. [Methyl-GAG, an effective cytotoxic drug for treatment of neoplastic exsudates (author's transl)].
    Tanneberger S; Matthias M; Rieche K
    Arch Geschwulstforsch; 1974; 43(1):68-74. PubMed ID: 4849186
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro studies of human tumor and embryonic tissue.
    Allen A; Ramon T; Jacobson A; Wade ME
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():8-14. PubMed ID: 4356757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.